DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
307. カナバン病
Canavan disease
Clinical trials
/
Disease details
臨床試験数
:
6
/
薬物数
:
11
- (
DrugBank
:
5
) /
標的遺伝子数
:
2
-
標的パスウェイ数
:
2
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT05317780
(
ClinicalTrials.gov
)
February 10, 2020
24/3/2022
Canavan-Single Patient IND
Expanded Access Trial of Systemic Delivery of Aspartoacylase ASPA (
rAAV9-CB6-AspA
) Gene Vector in a Single Patient With Canavan Disease
Expanded Access Trial of Systemic Delivery of Aspartoacylase ASPA (
rAAV9-CB6-AspA
) Gene Vector in a ...
Canavan Disease
Drug:
rAAV9-CB6-AspA
Barry J. Byrne
University of Miami;University of Massachusetts, Worcester
Available
18 Months
24 Months
Male
United States